| Ytd | 33.13% | |
| 1y | 7.40% |
| Open | 10.74 | Prev Close | 10.83 | Low | 10.64 | High | 11.23 | Mkt Cap | 1.13B |
| Vol | 1.58M | Avg Vol | 1.63M | EPS | -1.39 | P/E | N/A | Forward P/E | -6.75 |
| Beta | 1.06 | Short Ratio | 12.38 | Inst. Own | 114.17% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-04 | 50-d Avg | 8.93 | 200-d Avg | 10.66 | 1yr Est | 20.29 |
ORIC News
Dow futures up 400 points; Bandwidth Inc (BAND) falls after $275M offering; other stocks declining i
HC Wainwright & Co. analyst Robert Burns reiterates ORIC Pharmaceuticals (NASDAQ:ORIC) with a
Citigroup analyst Yigal Nochomovitz maintains ORIC Pharmaceuticals (NASDAQ:ORIC) with a Buy and l
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC), a clinical stage oncology company focused on developing tr
HC Wainwright & Co. analyst Robert Burns reiterates ORIC Pharmaceuticals (NASDAQ:ORIC) with a
Shares of Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) are tumbling Wednesday after the company announc
Wedbush analyst David Nierengarten maintains ORIC Pharmaceuticals (NASDAQ:ORIC) with a Outperform
US stock futures higher with Dow up 200 pts, Beyond Meat shares drop after downbeat results; ORIC, R
NKE: -10% | Nike shares are trading lower after the company reported Q3 financial results. Also, the
Shares of nCino Inc (NASDAQ: NCNO) jumped 18% in pre-market trading after reporting strong Q4 result
ORIC Pharmaceuticals stock rose after reporting positive cancer drug data and advancing to a Phase 3
Rinzimetostat 400 mg once daily selected as RP3D in combination with darolutamide for Himalayas-1 gl
ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing t
HC Wainwright & Co. analyst Robert Burns reiterates ORIC Pharmaceuticals (NASDAQ:ORIC) with a
U.S. stock futures lower, with Dow futures down over 1%. BETA Technologies (NYSE: BETA) fell in pre-
Lisata Therapeutics (LSTA) surged 20.3% to $5.03 in pre-market trading after agreeing to be taken pr
U.S. stock futures lower, Dow down 100 points. Methanex (MEOH) shares fall 8.7% after reporting quar
Citigroup analyst Yigal Nochomovitz maintains ORIC Pharmaceuticals (NASDAQ:ORIC) with a Buy and r
HC Wainwright & Co. analyst Robert Burns maintains ORIC Pharmaceuticals (NASDAQ:ORIC) with a
Wedbush analyst David Nierengarten reiterates ORIC Pharmaceuticals (NASDAQ:ORIC) with a Outperfor
ORIC Pharmaceuticals (NASDAQ:ORIC) reported quarterly losses of $(0.30) per share which beat the ana
Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analys
Gainers
Friday's session saw 236 companies set new 52-week lows.
On Monday, 413 companies reached new 52-week lows.
On Friday morning, 446 companies hit new 52-week lows.
Gainers
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 154.7% to settle at $12.10 on Tuesday
On Friday, 1043 companies hit new 52-week lows.
During Wednesday's trading, 435 companies set new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
Wednesday's session saw 784 companies set new 52-week lows.